SCHEMBL18800710

SCHEMBL18800710

CCOc1ccc(-c2nc(-c3ccc(C(=O)O)cc3)cc(N)c2C(=N)N)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ PRSS1 P07477 1/20 0.45
▸ PRSS2 P07478 1/20 0.45
▸ PRSS3 P35030 1/20 0.45
▸ PLA2G4B P0C869 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ ALPL P05186 1/20 0.44
▸ RXRA P19793 1/20 0.44
▸ RXRB P28702 1/20 0.44
▸ BTK Q06187 3/20 0.43
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ AHR P35869 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800711 0.85 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDNPC1LMNA
SCHEMBL18800676 0.85 BTK (0.60) PRSS1RXRARXRBBTKMAPT
SCHEMBL18800415 0.84 BTK (0.46) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL18800828 0.83 KDM4E (0.42) ALDH1A1KDM4ELMNAALPLBTK
SCHEMBL18800707 0.83 BTK (0.60) ALDH1A1KDM4EHPGDNPC1LMNA
SCHEMBL18800839 0.81 ADORA3 (0.41) ALDH1A1KDM4EHPGDNPC1RAB9A
SCHEMBL18800736 0.79 BTK (0.63) BTKCHEK2
SCHEMBL16168193 0.78 PARP10 (0.51) PRSS1PRSS2PRSS3BTKPARP10
SCHEMBL18800799 0.78 DYRK1A (0.49) ALDH1A1KDM4EHPGDNPC1LMNA
SCHEMBL16168188 0.77 ALDH1A1 (0.53) ALDH1A1HPGDRAB9ASMN1; SMN2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback